Cold plasma treatment of in vitro gliomas and patient-derived tumors – Role of human myeloid cells

Q1 Medicine
Sascha Marx , Frederik Kinnen , Juliane Moritz , Eric Freund , Mathias Stope , Sandra Bien-Möller , Bernhard H. Rauch , Christopher Ritter , Henry W.S. Schroeder , Sander Bekeschus
{"title":"Cold plasma treatment of in vitro gliomas and patient-derived tumors – Role of human myeloid cells","authors":"Sascha Marx ,&nbsp;Frederik Kinnen ,&nbsp;Juliane Moritz ,&nbsp;Eric Freund ,&nbsp;Mathias Stope ,&nbsp;Sandra Bien-Möller ,&nbsp;Bernhard H. Rauch ,&nbsp;Christopher Ritter ,&nbsp;Henry W.S. Schroeder ,&nbsp;Sander Bekeschus","doi":"10.1016/j.cpme.2017.12.009","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Tumor-associated macrophages (TAM) are the pre-dominant myeloid cells within </span>malignant glioma<span><span><span> and are a poor prognostic factor </span>in patients<span><span><span>. TAM in malignant glioma show a tumor-supporting, so-called M2 phenotype. The aim of this study was to characterize phenotype and relevant markers of monocytes/macrophages in the </span>tumor microenvironment following exposure to cold physical plasma Monocytes were enriched from </span>peripheral blood mononuclear cells derived from young healthy volunteers donating blood after </span></span>informed consent<span><span> and in accordance with the guidelines of the local ethics committee. Monocytes were co-cultured with a glioma cell line<span><span> (U87MG). The latter readily induced a M2 phenotype in these monocytes<span> as seen by an increase in CD163 expression. Prior to co-culture, either U87MG cells or monocytes were treated with an atmospheric pressure argon plasma jet (kINPen) for 15 seconds or 5 seconds, respectively. Non-treated co-cultures as well as single monocytes cultures served as controls. FACS immuno-phenotyping of monocytes/macrophages was performed for </span></span>CD55, CD97, CD162, CD163, CD169, CD204, CD276, HLA-DR, and HLA-ABC after 24h, 48h, and 72h. M2 polarization of monocytes by U87MG was neither attenuated nor reversed by plasma </span></span>treatment<span>. We next exposed primary glioblastoma patient material to cold physical plasma (kINPen) ex vivo. After treatment, tissues were incubated for 24h, and supernatants were collected. Multiplex cytokine analysis of supernatants. Results of five patients showed an absence of IFNα, IFNγ, IL12p70, IL17α, and IL23, and a presence of IL1β, TNFα, MCP1, IL6, IL8, IL10, IL18, and IL33 in samples. A mixed response was observed. For instance, both of the myeloid-cell interacting proteins MCP1 and IL1β are associated with glioma aggressiveness, and secretion of IL1β decreased after plasma treatment whereas MCP1 was increased. Glioma tissue sections will determine the distribution of myeloid cells within the tumor after plasma treatment compared to controls.</span></span></span></span><span><figure><span><img><ol><li><span>Download : <span>Download high-res image (136KB)</span></span></li><li><span>Download : <span>Download full-size image</span></span></li></ol></span></figure></span></p><p>Figure 1: Fold change of several chemokines/cytokines in kINPen plasma-treated primary human glioblastoma samples compared to untreated glioma tissue.</p></div>","PeriodicalId":46325,"journal":{"name":"Clinical Plasma Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cpme.2017.12.009","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Plasma Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212816617300343","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Tumor-associated macrophages (TAM) are the pre-dominant myeloid cells within malignant glioma and are a poor prognostic factor in patients. TAM in malignant glioma show a tumor-supporting, so-called M2 phenotype. The aim of this study was to characterize phenotype and relevant markers of monocytes/macrophages in the tumor microenvironment following exposure to cold physical plasma Monocytes were enriched from peripheral blood mononuclear cells derived from young healthy volunteers donating blood after informed consent and in accordance with the guidelines of the local ethics committee. Monocytes were co-cultured with a glioma cell line (U87MG). The latter readily induced a M2 phenotype in these monocytes as seen by an increase in CD163 expression. Prior to co-culture, either U87MG cells or monocytes were treated with an atmospheric pressure argon plasma jet (kINPen) for 15 seconds or 5 seconds, respectively. Non-treated co-cultures as well as single monocytes cultures served as controls. FACS immuno-phenotyping of monocytes/macrophages was performed for CD55, CD97, CD162, CD163, CD169, CD204, CD276, HLA-DR, and HLA-ABC after 24h, 48h, and 72h. M2 polarization of monocytes by U87MG was neither attenuated nor reversed by plasma treatment. We next exposed primary glioblastoma patient material to cold physical plasma (kINPen) ex vivo. After treatment, tissues were incubated for 24h, and supernatants were collected. Multiplex cytokine analysis of supernatants. Results of five patients showed an absence of IFNα, IFNγ, IL12p70, IL17α, and IL23, and a presence of IL1β, TNFα, MCP1, IL6, IL8, IL10, IL18, and IL33 in samples. A mixed response was observed. For instance, both of the myeloid-cell interacting proteins MCP1 and IL1β are associated with glioma aggressiveness, and secretion of IL1β decreased after plasma treatment whereas MCP1 was increased. Glioma tissue sections will determine the distribution of myeloid cells within the tumor after plasma treatment compared to controls.

  1. Download : Download high-res image (136KB)
  2. Download : Download full-size image

Figure 1: Fold change of several chemokines/cytokines in kINPen plasma-treated primary human glioblastoma samples compared to untreated glioma tissue.

体外胶质瘤和患者源性肿瘤的冷等离子体治疗——人髓细胞的作用
肿瘤相关巨噬细胞(TAM)是恶性胶质瘤中占主导地位的骨髓细胞,是患者预后不良的因素。恶性胶质瘤中的TAM表现为肿瘤支持型,即M2表型。本研究的目的是表征暴露于冷物理血浆后肿瘤微环境中单核/巨噬细胞的表型和相关标记物。在知情同意后,根据当地伦理委员会的指导,从年轻健康志愿者献血的外周血单核细胞中富集单核细胞。单核细胞与胶质瘤细胞系(U87MG)共培养。后者很容易在这些单核细胞中诱导M2表型,如CD163表达的增加所示。共培养前,U87MG细胞或单核细胞分别用常压氩等离子体射流(kINPen)处理15秒或5秒。未处理的共培养以及单个单核细胞培养作为对照。分别于24h、48h和72h对CD55、CD97、CD162、CD163、CD169、CD204、CD276、HLA-DR和HLA-ABC进行单核/巨噬细胞的FACS免疫表型分析。U87MG对单核细胞的M2极化既不减弱也不逆转。接下来,我们将原发性胶质母细胞瘤患者的材料在体外暴露于冷物理血浆(kINPen)中。处理后,组织孵育24h,收集上清。上清多重细胞因子分析。结果显示,5例患者样品中缺乏IFNα、IFNγ、IL12p70、IL17α和IL23,而存在IL1β、TNFα、MCP1、IL6、IL8、IL10、IL18和IL33。人们的反应不一。例如,骨髓细胞相互作用蛋白MCP1和il - 1β都与胶质瘤侵袭性有关,血浆治疗后il - 1β的分泌减少,而MCP1增加。与对照组相比,胶质瘤组织切片将确定血浆治疗后肿瘤内骨髓细胞的分布。图1:与未处理的胶质瘤组织相比,kINPen血浆处理的原发人胶质母细胞瘤样本中几种趋化因子/细胞因子的折叠变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Plasma Medicine
Clinical Plasma Medicine MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信